HK1092162A1 - Biologically active peptides comprising isoleucyl-valyl-threonyl- asparaginyl-threonyl-threonine (ivtntt) - Google Patents

Biologically active peptides comprising isoleucyl-valyl-threonyl- asparaginyl-threonyl-threonine (ivtntt)

Info

Publication number
HK1092162A1
HK1092162A1 HK06113884.6A HK06113884A HK1092162A1 HK 1092162 A1 HK1092162 A1 HK 1092162A1 HK 06113884 A HK06113884 A HK 06113884A HK 1092162 A1 HK1092162 A1 HK 1092162A1
Authority
HK
Hong Kong
Prior art keywords
threonyl
isoleucyl
asparaginyl
valyl
threonine
Prior art date
Application number
HK06113884.6A
Other languages
English (en)
Inventor
Wai Ming Wong
Kong Lam
Original Assignee
Cms Peptides Patent Holding Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cms Peptides Patent Holding Co filed Critical Cms Peptides Patent Holding Co
Publication of HK1092162A1 publication Critical patent/HK1092162A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK06113884.6A 2003-11-19 2006-12-18 Biologically active peptides comprising isoleucyl-valyl-threonyl- asparaginyl-threonyl-threonine (ivtntt) HK1092162A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52383703P 2003-11-19 2003-11-19
PCT/GB2004/004877 WO2005051981A1 (fr) 2003-11-19 2004-11-18 Peptides biologiquement actifs comprenant de l'isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (ivtntt)

Publications (1)

Publication Number Publication Date
HK1092162A1 true HK1092162A1 (en) 2007-02-02

Family

ID=34632832

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06113884.6A HK1092162A1 (en) 2003-11-19 2006-12-18 Biologically active peptides comprising isoleucyl-valyl-threonyl- asparaginyl-threonyl-threonine (ivtntt)

Country Status (10)

Country Link
US (1) US7396817B2 (fr)
EP (1) EP1689771B1 (fr)
JP (1) JP4614966B2 (fr)
KR (1) KR101258128B1 (fr)
CN (1) CN100434437C (fr)
AT (1) ATE420890T1 (fr)
DE (1) DE602004019141D1 (fr)
ES (1) ES2320899T3 (fr)
HK (1) HK1092162A1 (fr)
WO (1) WO2005051981A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides

Also Published As

Publication number Publication date
JP2008500272A (ja) 2008-01-10
ATE420890T1 (de) 2009-01-15
ES2320899T3 (es) 2009-05-29
CN1875032A (zh) 2006-12-06
CN100434437C (zh) 2008-11-19
EP1689771B1 (fr) 2009-01-14
EP1689771A1 (fr) 2006-08-16
DE602004019141D1 (de) 2009-03-05
WO2005051981A1 (fr) 2005-06-09
US20060234943A1 (en) 2006-10-19
KR101258128B1 (ko) 2013-05-06
US7396817B2 (en) 2008-07-08
JP4614966B2 (ja) 2011-01-19
KR20060103508A (ko) 2006-10-02

Similar Documents

Publication Publication Date Title
EP1778842B8 (fr) Compositions et procedes d'utilisation pour le facteur de stimulation de colonies de monocytes, de granulocytes et de cellules dendritiques dans le traitement de maladies
DE60019598D1 (de) Verbindungen zur behandlung von sexuellen funktionsstörungen
EP1728863A3 (fr) Analogues d'oligonucléotides de classe C présentant des propriétés immunostimulatrices accrues
ATE402957T1 (de) Analoge des menschlichen interferon-alpha mit niedriger toxizität
IL142905A0 (en) Functional antagonists of hedgehog activity
EP1319023B8 (fr) Peptide de hsp70 stimulant l'activite de cellules tueuses naturelles (nk) et ses utilisations
GB2367061A (en) Peptides
HK1092162A1 (en) Biologically active peptides comprising isoleucyl-valyl-threonyl- asparaginyl-threonyl-threonine (ivtntt)
NZ591827A (en) Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject
GB0203419D0 (en) Peptide
EP1812035A4 (fr) Agent antitumoral peptidique
GB0203420D0 (en) Peptide
MY138219A (en) Biologically active peptides
WO2001083722A3 (fr) Enzymes therapeutiques, et methodes de traitement du mps-vi et de lignees de cellules en vue de l'obtention de ces enzymes par recombinaison
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
JP2004533846A5 (fr)
EP1801216A3 (fr) Protéine immunotrope (CD14) associée à la lactation bovine, gène codant celle-ci et application de cette protéine dans une activation des lymphocytes B
EP1557466A4 (fr) Proteine d'antigene tumoral et utilisation de cette derniere
AU2001220255A1 (en) Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferationof cancer cell using the expression vector
RU2001105086A (ru) Новые пептиды для применения в иммунотерапии аутоиммунных заболеваний
DE60325227D1 (fr)
DE60223232D1 (de) Mucinpeptid mit immunstärkenden eigenschaften
WO2004011638A3 (fr) Polypeptides et structures de deoxyuridine 5' triphosphate nucleotidohydrolase
NZ509284A (en) Tumour antigen peptide derived from SART-that binds to HLA-A24 antigen thereby facilitating recognition by a T call
WO2003068925A3 (fr) Production d'un systeme d'administration de proteines destine a un traitement therapeutique in vivo

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151118